Medicine
Early University of Calgary trial tests high-dose niacin as add-on treatment for glioblastoma
Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli
Researchers at the University of Calgary are studying whether high doses of vitamin B3 (niacin) can improve outcomes for patients with newly diagnosed glioblastoma when added to standard treatment. An interim analysis of 24 patients found a higher-than-expected six‑month progression‑free survival rate, though investigators stress the results are preliminary and require ongoing safety monitoring.
A Newcastle University-led screening study of nearly 300 adults in northern Britain found persistently high rates of low vitamin D in older people and adults from minoritized ethnic groups, with little evidence that summer months substantially improved levels.
Imeripotiwa na AI
New research indicates that oestrogen levels, which vary across the menstrual cycle, can influence how efficiently some drugs reach the brain in women.
Two existing medications cooled core body temperature in animals after stroke and reduced brain damage. A small human trial showed limited effect due to slow delivery. Researchers are now planning a follow-up study with faster infusions.
Imeripotiwa na AI
Researchers at Texas A&M University have shown that mammals may possess dormant abilities to regrow complex body parts. A new two-step treatment redirected healing in mice away from scarring toward tissue regeneration. The approach restored bone, joints, ligaments and tendons after amputation.
Adults with obesity who began taking GLP-1 receptor agonist medications showed declines in Fitbit-measured physical activity after starting treatment, according to a retrospective study presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago.
Imeripotiwa na AI
Researchers have discovered that mutations in the CD99L2 gene cause X-linked spastic ataxia, a rare movement disorder. The finding came from analysis of 2,811 patients with conditions affecting coordination and muscle control. The study was published in Nature Communications.
French startup develops polymer liquid to aid nerve healing
Jumatatu, 22. Mwezi wa sita 2026, 15:15:32Woman with Alzheimer's regains speech after psilocybin treatment
Jumamosi, 20. Mwezi wa sita 2026, 12:05:11Study finds excessive EXO1 DNA-repair activity can destabilize genomes and may mark tumors sensitive to some therapies
Jumamosi, 20. Mwezi wa sita 2026, 04:21:18Updated POWER framework urges multidisciplinary obesity care beyond GLP-1 drugs
Jumamosi, 20. Mwezi wa sita 2026, 04:12:51Blood test can reveal Alzheimer's signs years ahead
Jumatano, 17. Mwezi wa sita 2026, 07:31:28Study finds genicular artery embolization reduced knee osteoarthritis pain for at least 12 months
Jumanne, 16. Mwezi wa sita 2026, 12:55:54Study presented at ENDO 2026 links semaglutide to fewer fractures in people with type 2 diabetes
Jumanne, 16. Mwezi wa sita 2026, 07:37:34Claims-data study finds many people with type 2 diabetes restart GLP-1 drugs after stopping
Jumatatu, 15. Mwezi wa sita 2026, 19:53:15Review finds calcium and vitamin D supplements offer little benefit
Jumatatu, 15. Mwezi wa sita 2026, 19:00:26SpectraCure launches rights issue to finance studies